首页> 美国卫生研究院文献>Oncology Letters >Frequent aberrant p53 and Fhit expression in endoscopically resected superficial hypopharyngeal cancer and esophageal cancer
【2h】

Frequent aberrant p53 and Fhit expression in endoscopically resected superficial hypopharyngeal cancer and esophageal cancer

机译:内镜切除的浅喉下咽癌和食管癌中频繁出现p53和Fhit表达异常

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In the last decade, the incidence rate of detection rate of superficial head, neck and esophageal squamous cell carcinomas has increased with the development of endoscopic imaging techniques. These cancers are thought to arise independently subsequent to tissue exposure to a common carcinogen e.g. alcohol or tobacco. This phenomenon has been termed field cancerization. To determine the molecular background of the development of hypopharyngeal squamous cell carcinomas (HPSCCs) and double esophageal squamous cell carcinomas (DESCCs), the present study immunohistochemically assessed tumor-related protein expression [p53, Fhit (fragile histidine triad), E-cadherin and activation-induced cytidine deaminase (AID)], and subsequently determined the correlation between protein expression and clinicopathological data. Tumor specimens of 9 HPSCCs and 9 DESCCs were endoscopically obtained from 8 patients with HPSCC. The 9 DESCCs, including 5 synchronous and 4 metachronous lesions, were all obtained from four patients with HPSCC. The overexpression of p53 and loss of Fhit expression was immunohistochemically detected in 8 (88.9%) and 8 (88.9%) of the 9 HPSCCs and in 8 (88.9%) and 8 (88.9%) of the 9 DESCCs, respectively, which demonstrated the high frequency of such expression. Additionally, 7 out of 9 HPSCCs, and 7 out of 9 DESCCs demonstrated aberrant expression of p53 and Fhit. The rate of aberrant AID and E-cadherin expression was 67 and 44% in HPSCCs and 44 and 44% in DESCC, respectively. These results suggested that aberrant p53 and Fhit expression was involved in the development of HPSCC and their DESCC, and that their expression may be used for the prediction of DESCC development in patients with HPSCC, thereby acting as a biomarker of field cancerization.
机译:在过去的十年中,随着内窥镜成像技术的发展,浅表头,颈和食道鳞状细胞癌的检出率已经上升。据认为,这些癌症是在组织暴露于常见致癌物后,例如癌症后独立发生的。烟酒。这种现象被称为野外癌化。为了确定下咽鳞状细胞癌(HPSCC)和双食管鳞状细胞癌(DESCC)发生的分子背景,本研究通过免疫组化方法评估了肿瘤相关蛋白的表达[p53,Fhit(易碎组氨酸三联体),E-钙粘蛋白和激活诱导的胞苷脱氨酶(AID)],随后确定了蛋白表达与临床病理数据之间的相关性。从8例HPSCC患​​者的内窥镜检查中获得了9个HPSCC和9个DESCC的肿瘤标本。 9例DESCC,包括5个同步病变和4个异时病变,均来自4例HPSCC患​​者。免疫组化检测到9种DESCC中的8种(88.9%)和8种(88.9%)以及9种DESCC中的8种(88.9%)和8种(88.9%)的免疫组织化学检测到p53的过度表达和Fhit表达的丧失。这种表达的频率很高。此外,9个HPSCC中的7个和9个DESCC中的7个显示出p53和Fhit的异常表达。在HPSCC中,AID和E-cadherin的异常表达率分别在DESCC中分别为67%和44%,在DESCC中分别为44%和44%。这些结果表明,异常的p53和Fhit表达参与了HPSCC和它们的DESCC的发展,并且它们的表达可以用于预测HPSCC患​​者的DESCC的发展,从而充当了现场癌变的生物标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号